Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats.

Autor: Barrett TD; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Palomino HL; School of Medicine, University of California at San Diego, San Diego, CA, USA., Brondstetter TI; Covenant Care, Palo Alto, CA, USA., Kanelakis KC; Office of Foods and Veterinary Medicine, U.S. Food and Drug Administration, Rockville, MD, USA., Wu X; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Yan W; Arcturus Therapeutics, San Diego, CA, USA., Merton KP; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Schoetens F; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Ma JY; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Skaptason J; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Gao J; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Tran DT; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Venkatesan H; Cardiovascular Metabolic Research, Janssen Pharmaceutical Companies of Johnson & Johnson, San Diego, CA, USA., Rosen MD; Aetheria Therapeutics, San Diego, CA, USA., Shankley NP; Higher Todsworthy Farm, Cornwall, UK., Rabinowitz MH; Aetheria Therapeutics, San Diego, CA, USA.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2015 Aug; Vol. 172 (16), pp. 4078-88. Date of Electronic Publication: 2015 Jun 26.